Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Colchicine Use for Primary Prevention in People at High Risk of Coronary Artery Disease

NCT05175274 is registered in ClinicalTrials.gov with Qingdao Central Hospital as lead sponsor.

NCT NCT05175274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05175274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Colchicine Use for Primary Prevention in People at High Risk of Coronary Artery Disease
Lead sponsor
Qingdao Central Hospital
Phase
Phase 3
Overall status
Not yet recruiting
Start date
December 6, 2022
Completion date
July 1, 2028
Enrollment
6,792 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease